Call Now

Bronchopulmonary Dysplasia (BPD)

Chronic lung disease of infancy

Bronchopulmonary dysplasia (BPD; formerly chronic lung disease of infancy) is a chronic lung disorder of infants and children first described in 1967. It is more common in infants with low birth weight and those who receive prolonged mechanical ventilation to treat respiratory distress syndrome (RDS). It results in significant morbidity and mortality. The definition of BPD has continued to evolve since then primarily due to changes in the population, such as more survivors at earlier gestational ages, and improved neonatal management including surfactant, antenatal glucocorticoid therapy, and less aggressive mechanical ventilation.

Organism species: Pan-species (General)

Proteins N/A Recombinant Bronchopulmonary Dysplasia (BPD) Antigenic Transformation Customized Service Offer
Antibodies N/A Monoclonal Antibody to Bronchopulmonary Dysplasia (BPD) Monoclonal Antibody Customized Service Offer
N/A Polyclonal Antibody to Bronchopulmonary Dysplasia (BPD) Polyclonal Antibody Customized Service Offer
Assay Kits N/A CLIA Kit for Bronchopulmonary Dysplasia (BPD) CLIA Kit Customized Service Offer
N/A ELISA Kit for Bronchopulmonary Dysplasia (BPD) ELISA Kit Customized Service Offer